Other substances

Carba-nicotinamide-adenine-dinucleotide

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

An approved drug for suppresion of withdrawal symptoms from various drug addictions (Vijayan et al., 2020).

Carba-nicotinamide-adenine-dinucleotide on DrugBank
Carba-nicotinamide-adenine-dinucleotide on PubChem

Synonyms

DB02498

 

Structure image - Carba-nicotinamide-adenine-dinucleotide

C1[C@@H]([C@H]([C@H]([C@@H]1[N+]2=CC=CC(=C2)C(=O)N)O)O)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O

Supporting references

Link Tested on Impact factor Notes Publication date
Identification of promising drug candidates against NSP16 of SARS-CoV-2 through computational drug repurposing study
in silico 3.31

In silico screening of NSP16 (viral methyltrasferase) inhibitors.

 Aug/03/2020
Export (.csv)